Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Testosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 13 Neoplasms 6 Breast Neoplasms 4 Hypogonadism 3 Eunuchism 3 Fatigue 2 Dyspareunia 2 Vaginitis 1 Testicular Neoplasms 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Polycystic Ovary Syndrome 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Muscle Weakness 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Metabolic Syndrome 1 Metabolic Diseases 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Infertility 1 Hot Flashes 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1

Interventions

Trastuzumab 26 Paclitaxel 26 Cyclophosphamide 26 Docetaxel 19 Doxorubicin 17 Taxes 16 Radiotherapy 13 Lapatinib 13 Tamoxifen 11 Capecitabine 11 Bevacizumab 11 Filgrastim 9 Carboplatin 9 Chemotherapy, Adjuvant 8 sargramostim 7 Immunohistochemistry 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 pegfilgrastim 6 exemestane 6 Vorinostat 6 Magnetic Resonance Spectroscopy 6 Letrozole 6 Goserelin 6 Gemcitabine 6 Anastrozole 6 Albumin-Bound Paclitaxel 6 ixabepilone 5 Vinorelbine 5 Peripheral Blood Stem Cell Transplantation 5 Neoadjuvant Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05156606 2024-08-09

T&T

University Medical Center Groningen

Phase NA Terminated

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡